CPHI Pharma Awards 2025 finalists announced

The shortlist of finalists for the CPHI Pharma Awards 2025 has been unveiled, with recognition for outstanding achievements across pharmaceutical innovation, manufacturing, sustainability, leadership and women in pharma.

Innovators from a range of key areas, including synthetic biology and AI-powered formulation, circular packaging and leadership in rare diseases, are highlighted among the nominees.

Tara Dougal, CPHI Event Director at Informa Markets, said: “Across every category, the finalists are setting new standards in pharmaceutical innovation, sustainability and patient impact. The CPHI Pharma Awards are a vital platform to spotlight the progress shaping the future of our industry.

“We’re looking forward to celebrating these achievements and announcing the winners on the opening day of CPHI Frankfurt.”

Further details about each finalist are available here and winners for each category will be announced on 28 October at CPHI Frankfurt 2025.

CPHI Pharma Awards 2025 Finalists

Sustainability

• Celtic Renewables: Leading the green chemical revolution, transforming industrial by-products into high-value green chemicals
• Enantios: Enantios platform – Enabling fast, label-free chiral analysis in solution
• Avantor: J.T.Baker Viral Inactivation Solution – Environmentally safer detergent for virus removal in bioprocessing
• AustinPx: KinetiSol technology, a solvent-free, fusion-based technology that transforms poorly soluble drugs into high-bioavailability formulations
• Kindeva: Leading the way in next-generation propellants (NGPs) – commercial-ready capabilities in HFA152a and HFO1234ze propellants.
• Alliance to Zero: Lean, green and secure, a regulatory-ready, blister-free, syringe solution
• Huhtamaki: Omnilock Ultra PAPER
• Botanical Solution Inc (BSI): Sustainability grows on trees: producing QS-21, the gold standard vaccine adjuvant.
  

Woman of the Year

• Adriana Kiędzierska-Mencfeld, Polpharma Biologics
• Christiane Bardroff, Rentschler Biopharma
• Ivy Gao, Sunresin
• Jennifer Gattari, Pfizer CentreOne
• Jonina Gudmundsdottir, Coripharma
• Meeta Gulyani, Ecolab Life Sciences.

CEO of the Year

• Bobby Sheng, Bora Pharmaceuticals
• Deepak Bahri, Sentiss Pharma
• Hanns-Christian Mahler, ten23 health
• Lars Petersen, FUJIFILM Diosynth Biotechnologies
• Lisa Soyeon Park, Prestige Biopharma
• Michael Quirmbach, CordenPharma International.

Future Leader

• Jakub Knurek, Mabion
• Mark Kelada, Nelipak Laboratory Services
• Mohammad Farahani, CinnaGen
• Yolanda Gomez, Esteve CDMO
• Yuvansh Khokhani, YSK Laboratories

Accelerating Innovation

• NunaBio Ltd: Custom, cell-free, synthetic DNA
• TriLink Biotechnologies: GMP-grade CleanCap M6 analog
• Covestro Deutschland: Mono-Material drug delivery demonstrator
• Accord Healthcare: Orgovyx – transforming prostate cancer care
• Invengene: Room temperature-stable generic posaconazole injection using hydroxypropyl beta-cyclodextrin (HPβCD)
• Prestige BioPharma: Ullenistamab – a targeted MAB for pancreatic cancer.

At the Heart of Pharma

• Accord Healthcare: A decade of impact with International Health Partners (IHP)
• PharmEvo: Elevating patient safety through intelligent design
• Strides: Enhancing access to affordable healthcare – HIV
• Farmak International: Resilient by Design – Farmak Group’s Ukrainian-rooted pharma network blueprint for crisis-proof global supply
• CNX Therapeutics and the Social Mobility Foundation: Talent without barriers.

Manufacturing Excellence

• Coriolis Pharma Research: Advanced lyophilisation modelling
• Enzene: EnzeneX – Fully-connected continuous manufacturing
• Bausch+Ströbel SE + Co. KG: GENEX, robotic, modular aseptic fill-finish platform
• VectorBuilder: VectorBuilder’s gene drug manufacturing platform.

Supply Chain Excellence

• Cryoport Systems: Integrated end-to-end supply chain platform
• Occam Systems: Resilient chemical supply chains, supercharged by AI
• QYOBO: QYOBO platform
• TraceLink: TraceLink Orchestration Platform for Universal Solutions (OPUS).

Finished Formulation

• Zerion Pharma: Dispersome technology
• Evonik Industries: EUDRACAP colon – the world’s first functional ready-to-fill capsule for oral drug delivery to target the ileo-colonic region
• CrystecPharma: Modified Supercritical Anti-Solvent (mSAS) particle engineering for stabilisation of biomolecules
• Roquette: ReadiLYCOAT plant-based coating systems for enhanced oral dosage solutions
• Lonza Capsules & Health Ingredients: Innovaform innovation and formulation accelerator.

Drug Delivery and Device Innovation

• Azelis Group: Advanced Peristomal Barrier & Adhesion Cream
• SHL Medical: Maggie Mix – A dual-chamber autoinjector with Needle Isolation Technology (NIT)
• LTS Lohmann Therapie Systems: Launching the first biosimilar in an on-body injector
• Ypsomed: Uniting sustainability and patient convenience in self-injection devices.

Packaging and Machinery

• SCHOTT Pharma: SCHOTT TOPPAC infuse – the next generation
• IMA LIFE: TILE-X: New generation gloveless aseptic fill-finish system
• H&T Presspart: Vytal innovative RTU snap-fit closure.

API Development and Innovation

• Lonza: Design2Optimize
• CMAC: From Crystallisation to Tablet – a scalable platform for API agglomeration
• Merck: mPredict co-crystal prediction service
• CordenPharma International: TAPS – TAG-assisted peptide synthesis.

Start-up Initiative

• Green Elephant Biotech: CellScrew
• NunaBio: Custom: Cell-free, synthetic DNA – including high complexity sequences, multi kilobase length and milligram scale – made in days to weeks
• NovoArc: Lipids for innovative drug formulation
• ORYL Photonics: ORYL F1.